{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T16:02:58Z","timestamp":1789488178750,"version":"build-2803163510"},"posted":{"date-parts":[[2026,9,11]]},"group-title":"Neurology","reference-count":23,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"Intramural Research Program of the National Institutes of Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,9,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Identifying and longitudinally measuring cognitive decline remains challenging because traditional assessments rely largely on episodic, in-person administration of analog scales by trained examiners. Smartphone technology provides a scalable alternative capable of extracting distinct digital biomarkers from continuous sensor and event streams. Following the integration of several cognitive modules into the self-administered Neurological Functions Test Suite (NeuFun-TS), this study evaluates the clinical utility and incremental validity of a final candidate module: an equiprobable (50\/50) continuous vigilance Go\/No-Go paradigm.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We analyzed 3,270 quality-controlled trials from 303 participants, focusing primary analyses on 488 first-trial observations across 34 healthy donors (HD) and 213 multiple sclerosis (MS) participants. From the raw event stream, we screened 16 candidate metrics and retained 10 based on their intrinsic psychometric properties. Using these 10 metrics, we evaluated diagnostic group separation, test-retest reliability, correlations with clinical and magnetic resonance imaging (MRI) benchmarks, and incremental validity over existing digital modules: the randomized Symbol Digit Modalities Test (rSDMT) and the Motor Sequencing Test (MST), using paired observations.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Although nine of the 10 outcomes significantly separated HD from MS and seven separated relapsing-remitting from progressive MS subtypes (all adjusted p &lt; 0.05), discriminative power was driven almost entirely by response latency rather than commission errors or inhibitory metrics. Multi-predictor composite scores offered no diagnostic advantage over reaction time alone. Furthermore, the Go\/No-Go task demonstrated poor-to-moderate longitudinal test-retest reliability and failed to provide incremental clinical value over existing modules.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Although the smartphone-based Go\/No-Go task reflects processing speed impairment in MS, its discriminative capability is redundant with simpler reaction time metrics already implemented in the platform. Consequently, the Go\/No-Go module was excluded from NeuFun-TS to minimize patient testing burden without compromising diagnostic sensitivity.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.09.09.26362640","type":"posted-content","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:05:14Z","timestamp":1789189514000},"source":"Crossref","is-referenced-by-count":0,"title":["Processing Speed Accounts for the Discriminative Power of a Smartphone Go\/No-Go Task in Multiple Sclerosis"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1392-0629","authenticated-orcid":false,"given":"Peter","family":"Kosa","sequence":"first","affiliation":[{"name":"Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2756-1265","authenticated-orcid":false,"given":"Amir","family":"Moghadam Ahmadi","sequence":"additional","affiliation":[{"name":"Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Kanu","sequence":"additional","affiliation":[{"name":"Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Mejia","sequence":"additional","affiliation":[{"name":"Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6847-9943","authenticated-orcid":false,"given":"Emmanuel","family":"Mekasha","sequence":"additional","affiliation":[{"name":"Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8564-0993","authenticated-orcid":false,"given":"Caledonia","family":"Steltzner","sequence":"additional","affiliation":[{"name":"Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0959-9430","authenticated-orcid":false,"given":"Bibiana","family":"Bielekova","sequence":"additional","affiliation":[{"name":"Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026091508100666000_2026.09.09.26362640v1.1","doi-asserted-by":"crossref","first-page":"106782","DOI":"10.1016\/j.msard.2025.106782","article-title":"Mobile-based cognitive screening tools in multiple sclerosis: Scoping literature and app store review","volume":"104","year":"2025","journal-title":"Multiple sclerosis and related disorders"},{"key":"2026091508100666000_2026.09.09.26362640v1.2","doi-asserted-by":"crossref","unstructured":"Balconi, J. , Langdon, D. , Dhakal, B. & Benedict, R.H.B . An Update on New Approaches to Cognitive Assessment in Multiple Sclerosis. NeuroSci 6(2025).","DOI":"10.3390\/neurosci6030087"},{"key":"2026091508100666000_2026.09.09.26362640v1.3","doi-asserted-by":"crossref","first-page":"104723","DOI":"10.1016\/j.msard.2023.104723","article-title":"Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)","volume":"74","year":"2023","journal-title":"Multiple sclerosis and related disorders"},{"key":"2026091508100666000_2026.09.09.26362640v1.4","doi-asserted-by":"crossref","unstructured":"Wojcik, C.M. , et al. Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review. Mult Scler, 1352458519879094 (2019).","DOI":"10.1177\/1352458519879094"},{"key":"2026091508100666000_2026.09.09.26362640v1.5","doi-asserted-by":"crossref","unstructured":"Boukhvalova, A.K. , et al. Identifying and Quantifying Neurological Disability via Smartphone. Frontiers in Neurology 9(2018).","DOI":"10.3389\/fneur.2018.00740"},{"key":"2026091508100666000_2026.09.09.26362640v1.6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00358"},{"key":"2026091508100666000_2026.09.09.26362640v1.7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41746-021-00401-y","article-title":"Smartphone-based symbol-digit modalities test reliably captures brain damage in multiple sclerosis","volume":"4","year":"2021","journal-title":"NPJ Digit Med"},{"key":"2026091508100666000_2026.09.09.26362640v1.8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1408224"},{"key":"2026091508100666000_2026.09.09.26362640v1.9","doi-asserted-by":"crossref","first-page":"1680389","DOI":"10.3389\/fdgth.2026.1680389","article-title":"Assessing verbal and spatial memory via smartphone","volume":"8","year":"2026","journal-title":"Front Digit Health"},{"key":"2026091508100666000_2026.09.09.26362640v1.10","doi-asserted-by":"crossref","unstructured":"Kosa, P. , et al. Decomposing cognitive-motor planning from execution: smartphone motor sequencing provides scalable digital biomarkers of cognitive-motor function across central nervous system disorders. medRxiv (2026).","DOI":"10.64898\/2026.07.30.26359238"},{"key":"2026091508100666000_2026.09.09.26362640v1.11","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-025-04038-2"},{"key":"2026091508100666000_2026.09.09.26362640v1.12","first-page":"714682","article-title":"Assessment of Smartphone-Based Spiral Tracing in Multiple Sclerosis Reveals Intra-Individual Reproducibility as a Major Determinant of the Clinical Utility of the Digital Test","volume":"3","year":"2021","journal-title":"Front Med Technol"},{"key":"2026091508100666000_2026.09.09.26362640v1.13","doi-asserted-by":"crossref","unstructured":"Kosa, P. , et al. NeurEx: digitalized neurological examination offers a novel high-resolution disability scale. Annals of clinical and translational neurology (2018).","DOI":"10.1002\/acn3.640"},{"key":"2026091508100666000_2026.09.09.26362640v1.14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.11.1444"},{"key":"2026091508100666000_2026.09.09.26362640v1.15","first-page":"131","article-title":"Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment","volume":"7","year":"2016","journal-title":"Front Neurol"},{"key":"2026091508100666000_2026.09.09.26362640v1.16","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.msard.2015.08.009","article-title":"Novel composite MRI scale correlates highly with disability in multiple sclerosis patients","volume":"4","year":"2015","journal-title":"Multiple sclerosis and related disorders"},{"key":"2026091508100666000_2026.09.09.26362640v1.17","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s40120-025-00736-8","article-title":"Evaluating Cognitive Outcomes in Multiple Sclerosis: Real-World Impact of Ozanimod on Processing Speed Using BICAMS","volume":"14","year":"2025","journal-title":"Neurol Ther"},{"key":"2026091508100666000_2026.09.09.26362640v1.18","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/s12883-024-03943-2","article-title":"Comparing cognitive impairment using MACFIMS in patients with multiple sclerosis and healthy controls: a systematic review and meta-analysis","volume":"24","year":"2024","journal-title":"BMC Neurol"},{"key":"2026091508100666000_2026.09.09.26362640v1.19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/acn3.51976","article-title":"Domain-specific cognitive impairment in multiple sclerosis: A systematic review and meta-analysis","volume":"11","year":"2024","journal-title":"Annals of clinical and translational neurology"},{"key":"2026091508100666000_2026.09.09.26362640v1.20","doi-asserted-by":"crossref","unstructured":"Lugosi, K. , et al. Cognitive Impairment in Multiple Sclerosis: The Role of Clinical and Sociodemographic Factors - A Systematic Review and Meta-Analysis. Annals of clinical and translational neurology (2025).","DOI":"10.1002\/acn3.70172"},{"key":"2026091508100666000_2026.09.09.26362640v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.tics.2013.12.003"},{"key":"2026091508100666000_2026.09.09.26362640v1.22","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.10.1368"},{"key":"2026091508100666000_2026.09.09.26362640v1.23","unstructured":"Team, R.C. R: A language and environment for statistical computing. R Foundation for Statistical Computing. (Vienna, Austria, 2025)."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.09.09.26362640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:10:17Z","timestamp":1789485017000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.09.09.26362640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":23,"URL":"https:\/\/doi.org\/10.64898\/2026.09.09.26362640","relation":{},"subject":[],"published":{"date-parts":[[2026,9,11]]},"subtype":"preprint"}}